Guido Moll, PhD

Guido Moll, PhD

Guido Moll has graduated in 2007 as Diploma Engineer in Medical Biotechnology from the Berlin Institute of Technology (TUB), specializing in MSC therapies, followed by his PhD and postdoc studies on MSC therapies with clinical MSC pioneers professors Katarina Le Blanc and Olle Ringdén at Karolinska Institutet in Stockholm, Sweden and clinical cell delivery and biocompatibility experts professors Bo Nilsson and Kristina Nilsson-Ekdahl at Ruedbeck Laboratory in Uppsala University, Sweden. In 2014, Guido secured postdoc funding within the German Excellence Initiative funded Berlin-Brandenburg School for Regenerative Therapies (BSRT) to continue his studies on optimizing cell therapies at the Berlin Institute of Health (BIH) Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin. Guido is currently working as assistant coordinator within in advanced EU-H2020-funded phase III clinical ATMP/GMP-projects on cellular therapeutics coordinated by professors Hans-Dieter Volk and Petra Reinke, directors of the BCRT and the Berlin Center for Advanced Therapies (BECAT), respectively.